Skip to main content

Increased Alternative Complement Pathway Function and Improved Survival during Critical Illness.

Publication ,  Journal Article
Bain, W; Li, H; van der Geest, R; Moore, SR; Olonisakin, TF; Ahn, B; Papke, E; Moghbeli, K; DeSensi, R; Rapport, S; Saul, M; Hulver, M; Ma, L ...
Published in: Am J Respir Crit Care Med
July 15, 2020

Rationale: Complement is crucial for host defense but may also drive dysregulated inflammation. There is limited understanding of alternative complement function, which can amplify all complement activity, during critical illness.Objectives: We examined the function and key components of the alternative complement pathway in a series of critically ill patients and in a mouse pneumonia model.Methods: Total classical (CH50) and alternative complement (AH50) function were quantified in serum from 321 prospectively enrolled critically ill patients and compared with clinical outcomes. Alternative pathway (AP) regulatory factors were quantified by ELISA (n = 181) and examined via transcriptomics data from external cohorts. Wild-type, Cfb-/-, and C3-/- mice were infected intratracheally with Klebsiella pneumoniae (KP) and assessed for extrapulmonary dissemination.Measurements and Main Results: AH50 greater than or equal to median, but not CH50 greater than or equal to median, was associated with decreased 30-day mortality (adjusted odds ratio [OR], 0.53 [95% confidence interval (CI), 0.31-0.91]), independent of chronic liver disease. One-year survival was improved in patients with AH50 greater than or equal to median (adjusted hazard ratio = 0.59 [95% CI, 0.41-0.87]). Patients with elevated AH50 had increased levels of AP factors B, H, and properdin, and fewer showed a "hyperinflammatory" subphenotype (OR, 0.30 [95% CI, 0.18-0.49]). Increased expression of proximal AP genes was associated with improved survival in two external cohorts. AH50 greater than or equal to median was associated with fewer bloodstream infections (OR, 0.67 [95% CI, 0.45-0.98). Conversely, depletion of AP factors, or AH50 less than median, impaired in vitro serum control of KP that was restored by adding healthy serum. Cfb-/- mice demonstrated increased extrapulmonary dissemination and serum inflammatory markers after intratracheal KP infection compared with wild type.Conclusions: Elevated AP function is associated with improved survival during critical illness, possibly because of enhanced immune capacity.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Am J Respir Crit Care Med

DOI

EISSN

1535-4970

Publication Date

July 15, 2020

Volume

202

Issue

2

Start / End Page

230 / 240

Location

United States

Related Subject Headings

  • Survival Analysis
  • Retrospective Studies
  • Respiratory System
  • Pneumonia
  • Pennsylvania
  • Middle Aged
  • Mice
  • Male
  • Humans
  • Female
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Bain, W., Li, H., van der Geest, R., Moore, S. R., Olonisakin, T. F., Ahn, B., … Lee, J. S. (2020). Increased Alternative Complement Pathway Function and Improved Survival during Critical Illness. Am J Respir Crit Care Med, 202(2), 230–240. https://doi.org/10.1164/rccm.201910-2083OC
Bain, William, Huihua Li, Rick van der Geest, Sara R. Moore, Tolani F. Olonisakin, Brian Ahn, Erin Papke, et al. “Increased Alternative Complement Pathway Function and Improved Survival during Critical Illness.Am J Respir Crit Care Med 202, no. 2 (July 15, 2020): 230–40. https://doi.org/10.1164/rccm.201910-2083OC.
Bain W, Li H, van der Geest R, Moore SR, Olonisakin TF, Ahn B, et al. Increased Alternative Complement Pathway Function and Improved Survival during Critical Illness. Am J Respir Crit Care Med. 2020 Jul 15;202(2):230–40.
Bain, William, et al. “Increased Alternative Complement Pathway Function and Improved Survival during Critical Illness.Am J Respir Crit Care Med, vol. 202, no. 2, July 2020, pp. 230–40. Pubmed, doi:10.1164/rccm.201910-2083OC.
Bain W, Li H, van der Geest R, Moore SR, Olonisakin TF, Ahn B, Papke E, Moghbeli K, DeSensi R, Rapport S, Saul M, Hulver M, Xiong Z, Mallampalli RK, Ray P, Morris A, Ma L, Doi Y, Zhang Y, Kitsios GD, Kulkarni HS, McVerry BJ, Ferreira VP, Nouraie M, Lee JS. Increased Alternative Complement Pathway Function and Improved Survival during Critical Illness. Am J Respir Crit Care Med. 2020 Jul 15;202(2):230–240.

Published In

Am J Respir Crit Care Med

DOI

EISSN

1535-4970

Publication Date

July 15, 2020

Volume

202

Issue

2

Start / End Page

230 / 240

Location

United States

Related Subject Headings

  • Survival Analysis
  • Retrospective Studies
  • Respiratory System
  • Pneumonia
  • Pennsylvania
  • Middle Aged
  • Mice
  • Male
  • Humans
  • Female